Navin Mahadevan is a Rare/Genetic physician. OpenAlex indexes 251 publications with 3,399 citations (h-index 29).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingNIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Targeting the immunologic vulnerabilities of small cell lung carcinoma
University of Michigan at Ann Arbor
FY2026$207,930K08CA270077 - Targeting the immunologic vulnerabilities of small cell lung carcinoma
University of Michigan at Ann Arbor
FY2025$207,930K08CA270077 - Targeting the immunologic vulnerabilities of small cell lung carcinoma
University of Michigan at Ann Arbor
FY2024$191,961K08CA270077
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Ronald Wapner, MD
Columbia University Irving Medical Center
Virginia Kimonis, MD
UC Irvine School of Medicine
Robert Hopkin, MD
Cincinnati Children's Hospital Medical Center
Joel Charrow, MD
Northwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”